379 related articles for article (PubMed ID: 24856557)
1. S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of response.
Sarris J; Papakostas GI; Vitolo O; Fava M; Mischoulon D
J Affect Disord; 2014 Aug; 164():76-81. PubMed ID: 24856557
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder.
Mischoulon D; Price LH; Carpenter LL; Tyrka AR; Papakostas GI; Baer L; Dording CM; Clain AJ; Durham K; Walker R; Ludington E; Fava M
J Clin Psychiatry; 2014 Apr; 75(4):370-6. PubMed ID: 24500245
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM
Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
[TBL] [Abstract][Full Text] [Related]
4. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
Azorin JM; Llorca PM; Despiegel N; Verpillat P
Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
[TBL] [Abstract][Full Text] [Related]
5. S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial.
Papakostas GI; Mischoulon D; Shyu I; Alpert JE; Fava M
Am J Psychiatry; 2010 Aug; 167(8):942-8. PubMed ID: 20595412
[TBL] [Abstract][Full Text] [Related]
6. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
[TBL] [Abstract][Full Text] [Related]
7. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
Waugh J; Goa KL
CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder.
Mischoulon D; Alpert JE; Arning E; Bottiglieri T; Fava M; Papakostas GI
J Clin Psychiatry; 2012 Jun; 73(6):843-8. PubMed ID: 22687580
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
[TBL] [Abstract][Full Text] [Related]
10. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
Burke WJ; Gergel I; Bose A
J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
[TBL] [Abstract][Full Text] [Related]
11. Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder.
Soares CN; Thase ME; Clayton A; Guico-Pabia CJ; Focht K; Jiang Q; Kornstein SG; Ninan P; Kane CP; Cohen LS
Menopause; 2010 Jul; 17(4):700-11. PubMed ID: 20539246
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.
Bobo WV; Chen H; Trivedi MH; Stewart JW; Nierenberg AA; Fava M; Kurian BT; Warden D; Morris DW; Luther JF; Husain MM; Cook IA; Lesser IM; Kornstein SG; Wisniewski SR; Rush AJ; Shelton RC
J Affect Disord; 2011 Oct; 133(3):467-76. PubMed ID: 21601287
[TBL] [Abstract][Full Text] [Related]
13. Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical Trial.
Sarris J; Price LH; Carpenter LL; Tyrka AR; Ng CH; Papakostas GI; Jaeger A; Fava M; Mischoulon D
Pharmacopsychiatry; 2015 Jul; 48(4-5):141-4. PubMed ID: 26011569
[TBL] [Abstract][Full Text] [Related]
14. [Escitalopram for treatment of major depressive disorder in adults].
Llorca PM; Brousse G; Schwan R
Encephale; 2005; 31(4 Pt 1):490-501. PubMed ID: 16389716
[TBL] [Abstract][Full Text] [Related]
15. Dose increase of S-Adenosyl-Methionine and escitalopram in a randomized clinical trial for major depressive disorder.
Sakurai H; L Carpenter L; R Tyrka A; Price LH; I Papakostas G; Dording CM; Yeung AS; Cusin C; Ludington E; Bernard-Negron R; Fava M; Mischoulon D
J Affect Disord; 2020 Feb; 262():118-125. PubMed ID: 31733455
[TBL] [Abstract][Full Text] [Related]
16. Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.
Mao PX; Tang YL; Jiang F; Shu L; Gu X; Li M; Qian M; Ma C; Mitchell PB; Cai ZJ
Depress Anxiety; 2008; 25(1):46-54. PubMed ID: 17149753
[TBL] [Abstract][Full Text] [Related]
17. Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot study.
Franco-Chaves JA; Mateus CF; Luckenbaugh DA; Martinez PE; Mallinger AG; Zarate CA
J Affect Disord; 2013 Jul; 149(1-3):319-25. PubMed ID: 23517885
[TBL] [Abstract][Full Text] [Related]
18. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
Lam RW; Lönn SL; Despiégel N
Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
[TBL] [Abstract][Full Text] [Related]
19. Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial.
Kornstein SG; Bose A; Li D; Saikali KG; Gandhi C
J Clin Psychiatry; 2006 Nov; 67(11):1767-75. PubMed ID: 17196058
[TBL] [Abstract][Full Text] [Related]
20. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
